Download in electronic PDF format for $65

Abstract:  Compounding pharmacists throughout the world are compounding a special type of capsule called "slow-release." This type of capsule is a compounding pharmacy application of the commercial hydrophilic matrix tablets. It is a relatively simple system that allows formulating a robust, reliable, and consistent drug system based on 30% w/w to 40% w/w of specific types of hydroxypropyl methylcellulose. The main purpose of these capsules is to attenuate the drug release when there is a clinical need and no commercial medication exists. Five in vitro trials verified and proved this kind of preparation can be compounded by specialized pharmacists achieving substantial attenuation of drug release that resembles the pharmacokinetic profiles of commercial slow-release medications. An in-depth explanation of the mechanism of action of the slow-release capsules is provided. Since the pharmaceutical calculations needed to compound this preparation are time consuming, a suggestion of a faster way to perform these calculations by using a special Excel spreadsheet is provided. The article demonstrates a special table with a comparison between the specifications, results, and conclusions of the five in vitro trials that evaluated the pharmacokinetic rates of compounded slow-release capsules. The regulatory aspect of compounding slow-release capsules is also discussed.

Related Keywords: Eyal Zur, RPh, MBA, slow-release capsules, hydrophilic matrix tablets, hydroxypropyl methylcellulose, HPMC, attenuated drug release, calculation tool, software, spreadsheet, computer-aided calculations, gel strength, excipients, fillers, liothyronine, T3, formulation, uniformity tests, dissolution tests, regulation, terminology, pharmacokinetics, in vitro trials

Related Categories: EXCIPIENTS, SUPPORT, TECHNOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Zur Eyal	Jan/Feb 2013 Pg. 10-22
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N	Sep/Oct 2017 Pg. 418-425
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix Timmons Evelyn D, Timmons Steven P	Sep/Oct 2002 Pg. 379
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Bogner Robin H, Szwejkowski Jessica, Houston Alana	Sep/Oct 2001 Pg. 401-405
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 545
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 547
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Allen Loyd V Jr	Nov/Dec 2008 Pg. 548
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Webster Kathy D, Al-Achi Antoine, Greenwood Robert	Sep/Oct 1999 Pg. 409-411
Calculations Prince Shelly J	Jul/Aug 2003 Pg. 294
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Glowiak Dana L, Green Julie L, Bowman Bill J	Mar/Apr 2005 Pg. 157-164